BJ
LOXO

BlackRock Japan’s Loxo Oncology, Inc LOXO Stock Holding History

BlackRock Japan’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-918
Closed -$17K – 1412
2015
Q2 		$17K Sell
918
-2,004
-69% -$27.4K ﹤0.01% 1220
2015
Q1 		$36K Sell
2,922
-441
-13% -$5.49K ﹤0.01% 1122
2014
Q4 		$40K Buy
+3,363
New +$39.2K ﹤0.01% 1130

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlackRock Japan's LOXO Position: Q3 2015 in Review

BlackRock Japan sold out of Loxo Oncology, Inc (LOXO) in Q3 2015, closing a stake of 918 shares — an estimated $17K sold.

BlackRock Japan first reported a position in LOXO in Q4 2014 and held it in 3 quarters. The position peaked at $40K in Q4 2014. 51 funds tracked by Wall St. Rank hold LOXO as of Q3 2015.

  • BlackRock Japan reported no remaining Loxo Oncology, Inc position as of Q3 2015 after selling out during the quarter.
  • BlackRock Japan sold 918 Loxo Oncology, Inc shares in Q3 2015, an estimated $17K.
  • BlackRock Japan first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 3 quarters.
  • BlackRock Japan's Loxo Oncology, Inc position peaked at $40K in Q4 2014.
  • 51 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2015.

Based on BlackRock Japan's 13F filing for Q3 2015, filed 13 Nov 2015.